These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8816957)

  • 21. Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both.
    Luke CJ; Marshall MA; Zahradnik JM; Bybel M; Menefee BE; Barbour AG
    J Infect Dis; 2000 Mar; 181(3):1062-8. PubMed ID: 10720532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of peptide-antigen immunoassays for Lyme disease.
    Porwancher RB
    J Infect Dis; 2004 May; 189(10):1962; author reply 1962-4. PubMed ID: 15122535
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid.
    Skogman BH; Croner S; Forsberg P; Ernerudh J; Lahdenne P; Sillanpää H; Seppälä I
    Pediatr Infect Dis J; 2008 Jul; 27(7):605-12. PubMed ID: 18536620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
    Nyman D; Willén L; Jansson C; Carlsson SA; Granlund H; Wahlberg P
    Clin Microbiol Infect; 2006 May; 12(5):496-7. PubMed ID: 16643532
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of the immunoblot test in the diagnosis of Lyme borreliosis].
    Honegr K; Hulínská D; Havlasová J; Dostál V
    Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):149-54. PubMed ID: 9471305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-well ELISA based on independent peptide antigens for antibody capture. Application to Lyme disease serodiagnosis.
    Yu Z; Carter JM; Sigal LH; Stein S
    J Immunol Methods; 1996 Oct; 198(1):25-33. PubMed ID: 8914594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adsorption with a soluble E. coli antigen fraction improves the specificity of ELISA tests for Lyme disease.
    Fawcett PT; Gibney KM; Rose CD; Klein JD; Doughty RA
    J Rheumatol; 1991 May; 18(5):705-8. PubMed ID: 1713972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an immunoreactive non-proteinaleous component in Borrelia burgdorferi.
    Eiffert H; Lotter H; Jarecki-Khan K; Thomssen R
    Med Microbiol Immunol; 1991; 180(5):229-37. PubMed ID: 1722277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying diagnostic peptides for lyme disease through epitope discovery.
    Kouzmitcheva GA; Petrenko VA; Smith GP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):150-60. PubMed ID: 11139210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lyme disease serology in cattle.
    Cranwell MP; Cutler SJ
    Vet Rec; 1996 Jun; 138(22):551-2. PubMed ID: 8782365
    [No Abstract]   [Full Text] [Related]  

  • 32. Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.
    Fikrig E; Berland R; Chen M; Williams S; Sigal LH; Flavell RA
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):183-7. PubMed ID: 7678336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding characteristics of bovine serum albumin-aflatoxin B1 to polystyrene microtiter plates: importance of hapten to carrier protein molar ratio.
    Vyjayanthi V; Capoor AK; Sashidhar RB
    Indian J Exp Biol; 1995 May; 33(5):329-32. PubMed ID: 7558191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.
    Hamby CV; Llibre M; Utpat S; Wormser GP
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):801-7. PubMed ID: 16002626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serologic diagnosis of Borrelia burgdorferi infection].
    Hofstad H
    Tidsskr Nor Laegeforen; 1987 Dec; 107(34-36):3038-40. PubMed ID: 3433272
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic B-cell epitopes on the flagellar protein of Borrelia burgdorferi.
    Schneider T; Lange R; Rönspeck W; Weigelt W; Kölmel HW
    Infect Immun; 1992 Jan; 60(1):316-9. PubMed ID: 1370277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease.
    Pozsgay V; Kubler-Kielb J; Coxon B; Marques A; Robbins JB; Schneerson R
    Carbohydr Res; 2011 Sep; 346(12):1551-63. PubMed ID: 21601180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-linked immunosorbent assay for analysis of ochratoxin A in human plasma samples using antibodies raised against a new ochratoxin-protein conjugate.
    Breitholtz Emanuelsson A; Hult K
    IARC Sci Publ; 1991; (115):89-92. PubMed ID: 1820358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mimicry in Lyme disease: monoclonal antibody H9724 to B. burgdorferi flagellin specifically detects chaperonin-HSP60.
    Dai Z; Lackland H; Stein S; Li Q; Radziewicz R; Williams S; Sigal LH
    Biochim Biophys Acta; 1993 Mar; 1181(1):97-100. PubMed ID: 8096152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactive epitopes on an expressed recombinant flagellar protein of Borrelia burgdorferi.
    Collins C; Peltz G
    Infect Immun; 1991 Feb; 59(2):514-20. PubMed ID: 1702766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.